<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>amifostine</title><link>http://www.unboundmedicine.com/medline/ebm/research/amifostine</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Cisplatin overdose: toxicities and management.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19916578/full_citation/Cisplatin_overdose:_toxicities_and_management_</link><description>Tsang RY, Al-Fayea T, Au HJ <br/><span class="title">Cisplatin overdose: toxicities and management. [Journal Article]</span><br/><span class="source" title="Drug safety : an international journal of medical toxicology and drug experience">Drug Saf 2009; 32(12):1109-22.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19916578/abstract/Cisplatin_overdose:_toxicities_and_management_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19916578/full_citation/Cisplatin_overdose:_toxicities_and_management_">Full Citation</a></description></item><item><title>Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19915842/full_citation/Kidney_protection_during_peptide_receptor_radionuclide_therapy_with_somatostatin_analogues_</link><description>Rolleman EJ, Melis M, Valkema R, et al. <br/><span class="title">Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues. [JOURNAL ARTICLE]</span><br/><span class="source" title="European journal of nuclear medicine and molecular imaging">Eur J Nucl Med Mol Imaging 2009 Nov 14.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19915842/abstract/Kidney_protection_during_peptide_receptor_radionuclide_therapy_with_somatostatin_analogues_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19915842/full_citation/Kidney_protection_during_peptide_receptor_radionuclide_therapy_with_somatostatin_analogues_">Full Citation</a></description></item><item><title>Antiretroviral activity of the aminothiol WR1065 against Human Immunodeficiency virus (HIV-1) in vitro and Simian Immunodeficiency virus (SIV) ex vivo.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19895691/full_citation/Antiretroviral_activity_of_the_aminothiol_WR1065_against_Human_Immunodeficiency_virus__HIV_1__in_vitro_and_Simian_Immunodeficiency_virus__SIV__ex_vivo_</link><description>Poirier MC, Olivero OA, Hardy AW, et al. <br/><span class="title">Antiretroviral activity of the aminothiol WR1065 against Human Immunodeficiency virus (HIV-1) in vitro and Simian Immunodeficiency virus (SIV) ex vivo. [JOURNAL ARTICLE]</span><br/><span class="source" title="AIDS research and therapy">AIDS Res Ther 2009 Nov 6; 6(1):24.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19895691/abstract/Antiretroviral_activity_of_the_aminothiol_WR1065_against_Human_Immunodeficiency_virus__HIV_1__in_vitro_and_Simian_Immunodeficiency_virus__SIV__ex_vivo_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19895691/full_citation/Antiretroviral_activity_of_the_aminothiol_WR1065_against_Human_Immunodeficiency_virus__HIV_1__in_vitro_and_Simian_Immunodeficiency_virus__SIV__ex_vivo_">Full Citation</a></description></item><item><title>Analysis of the cytoprotective effect of amifostine on the irradiated inner ear of guinea pigs: an experimental study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19893938/full_citation/Analysis_of_the_cytoprotective_effect_of_amifostine_on_the_irradiated_inner_ear_of_guinea_pigs:_an_experimental_study_</link><description>Lessa RM, de Oliveira JA, Rossato M, et al. <br/><span class="title">Analysis of the cytoprotective effect of amifostine on the irradiated inner ear of guinea pigs: an experimental study. [Journal Article]</span><br/><span class="source" title="Brazilian journal of otorhinolaryngology">Braz J Otorhinolaryngol 2009 Sep-Oct; 75(5):694-700.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19893938/abstract/Analysis_of_the_cytoprotective_effect_of_amifostine_on_the_irradiated_inner_ear_of_guinea_pigs:_an_experimental_study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19893938/full_citation/Analysis_of_the_cytoprotective_effect_of_amifostine_on_the_irradiated_inner_ear_of_guinea_pigs:_an_experimental_study_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19893938/Analysis_of_the_cytoprotective_effect_of_amifostine_on_the_irradiated_inner_ear_of_guinea_pigs:_an_experimental_study_">Find Related Articles</a> </description></item><item><title>Phase I/II Trial of Bevacizumab and Radiotherapy for Locally Advanced Inoperable Colorectal Cancer: Vasculature-Independent Radiosensitizing Effect of Bevacizumab.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19887481/full_citation/Phase_I/II_Trial_of_Bevacizumab_and_Radiotherapy_for_Locally_Advanced_Inoperable_Colorectal_Cancer:_Vasculature_Independent_Radiosensitizing_Effect_of_Bevacizumab_</link><description>Koukourakis MI, Giatromanolaki A, Sheldon H, et al. <br/><span class="title">Phase I/II Trial of Bevacizumab and Radiotherapy for Locally Advanced Inoperable Colorectal Cancer: Vasculature-Independent Radiosensitizing Effect of Bevacizumab. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical cancer research : an official journal of the American Association for Cancer Research">Clin Cancer Res 2009 Nov 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19887481/abstract/Phase_I/II_Trial_of_Bevacizumab_and_Radiotherapy_for_Locally_Advanced_Inoperable_Colorectal_Cancer:_Vasculature_Independent_Radiosensitizing_Effect_of_Bevacizumab_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19887481/full_citation/Phase_I/II_Trial_of_Bevacizumab_and_Radiotherapy_for_Locally_Advanced_Inoperable_Colorectal_Cancer:_Vasculature_Independent_Radiosensitizing_Effect_of_Bevacizumab_">Full Citation</a></description></item><item><title>Quality of Life Supersedes the Classic Prognosticators for Long-Term Survival in Locally Advanced Non-Small-Cell Lung Cancer: An Analysis of RTOG 9801.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19858383/full_citation/Quality_of_Life_Supersedes_the_Classic_Prognosticators_for_Long_Term_Survival_in_Locally_Advanced_Non_Small_Cell_Lung_Cancer:_An_Analysis_of_RTOG_9801_</link><description>Movsas B, Moughan J, Sarna L, et al. <br/><span class="title">Quality of Life Supersedes the Classic Prognosticators for Long-Term Survival in Locally Advanced Non-Small-Cell Lung Cancer: An Analysis of RTOG 9801. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of clinical oncology : official journal of the American Society of Clinical Oncology">J Clin Oncol 2009 Oct 26.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19858383/abstract/Quality_of_Life_Supersedes_the_Classic_Prognosticators_for_Long_Term_Survival_in_Locally_Advanced_Non_Small_Cell_Lung_Cancer:_An_Analysis_of_RTOG_9801_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19858383/full_citation/Quality_of_Life_Supersedes_the_Classic_Prognosticators_for_Long_Term_Survival_in_Locally_Advanced_Non_Small_Cell_Lung_Cancer:_An_Analysis_of_RTOG_9801_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19858383/Quality_of_Life_Supersedes_the_Classic_Prognosticators_for_Long_Term_Survival_in_Locally_Advanced_Non_Small_Cell_Lung_Cancer:_An_Analysis_of_RTOG_9801_">Find Related Articles</a> </description></item><item><title>Postoperative accelerated radiotherapy with cytoprotection followed by three-dimensional conformal boost in patients with early endometrial/cervical cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19856656/full_citation/Postoperative_accelerated_radiotherapy_with_cytoprotection_followed_by_three_dimensional_conformal_boost_in_patients_with_early_endometrial/cervical_cancer_</link><description>Koukourakis MI, Tsoutsou PG, Abatzoglou I, et al. <br/><span class="title">Postoperative accelerated radiotherapy with cytoprotection followed by three-dimensional conformal boost in patients with early endometrial/cervical cancer. [Journal Article]</span><br/><span class="source" title="">Tumori 2009 Jul-Aug; 95(4):455-60.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19856656/abstract/Postoperative_accelerated_radiotherapy_with_cytoprotection_followed_by_three_dimensional_conformal_boost_in_patients_with_early_endometrial/cervical_cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19856656/full_citation/Postoperative_accelerated_radiotherapy_with_cytoprotection_followed_by_three_dimensional_conformal_boost_in_patients_with_early_endometrial/cervical_cancer_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19856656/Postoperative_accelerated_radiotherapy_with_cytoprotection_followed_by_three_dimensional_conformal_boost_in_patients_with_early_endometrial/cervical_cancer_">Find Related Articles</a> </description></item><item><title>Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19821441/full_citation/Amifostine_for_salivary_glands_in_high_dose_radioactive_iodine_treated_differentiated_thyroid_cancer_</link><description>Ma C, Xie J, Chen Q, et al. <br/><span class="title">Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer. [Journal Article]</span><br/><span class="source" title="Cochrane database of systematic reviews (Online)">Cochrane Database Syst Rev 2009; (4):CD007956.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19821441/abstract/Amifostine_for_salivary_glands_in_high_dose_radioactive_iodine_treated_differentiated_thyroid_cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19821441/full_citation/Amifostine_for_salivary_glands_in_high_dose_radioactive_iodine_treated_differentiated_thyroid_cancer_">Full Citation</a> | <a href="http://dx.doi.org/10.1002/14651858.CD007956.pub2">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19821441/Amifostine_for_salivary_glands_in_high_dose_radioactive_iodine_treated_differentiated_thyroid_cancer_">Find Related Articles</a> </description></item><item><title>Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19813275/full_citation/Amifostine_does_not_prevent_platinum_induced_hearing_loss_associated_with_the_treatment_of_children_with_hepatoblastoma:_a_report_of_the_Intergroup_Hepatoblastoma_Study_P9645_as_a_part_of_the_Children's_Oncology_Group_</link><description>Katzenstein HM, Chang KW, Krailo M, et al. <br/><span class="title">Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cancer">Cancer 2009 Oct 7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19813275/abstract/Amifostine_does_not_prevent_platinum_induced_hearing_loss_associated_with_the_treatment_of_children_with_hepatoblastoma:_a_report_of_the_Intergroup_Hepatoblastoma_Study_P9645_as_a_part_of_the_Children's_Oncology_Group_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19813275/full_citation/Amifostine_does_not_prevent_platinum_induced_hearing_loss_associated_with_the_treatment_of_children_with_hepatoblastoma:_a_report_of_the_Intergroup_Hepatoblastoma_Study_P9645_as_a_part_of_the_Children's_Oncology_Group_">Full Citation</a> | <a href="http://dx.doi.org/10.1002/cncr.24667">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19813275/Amifostine_does_not_prevent_platinum_induced_hearing_loss_associated_with_the_treatment_of_children_with_hepatoblastoma:_a_report_of_the_Intergroup_Hepatoblastoma_Study_P9645_as_a_part_of_the_Children's_Oncology_Group_">Find Related Articles</a> </description></item><item><title>Amifostine (WR2721) Confers DNA Protection to In Vivo Cisplatin-Treated Murine Peripheral Blood Leukocytes.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19809542/full_citation/Amifostine__WR2721__Confers_DNA_Protection_to_In_Vivo_Cisplatin_Treated_Murine_Peripheral_Blood_Leukocytes_</link><description>Prieto González EA, Fuchs AG, Sánchez GS <br/><span class="title">Amifostine (WR2721) Confers DNA Protection to In Vivo Cisplatin-Treated Murine Peripheral Blood Leukocytes. [Journal Article]</span><br/><span class="source" title="Dose-response : a publication of International Hormesis Society">Dose Response 2009; 7(3):234-46.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19809542/abstract/Amifostine__WR2721__Confers_DNA_Protection_to_In_Vivo_Cisplatin_Treated_Murine_Peripheral_Blood_Leukocytes_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19809542/full_citation/Amifostine__WR2721__Confers_DNA_Protection_to_In_Vivo_Cisplatin_Treated_Murine_Peripheral_Blood_Leukocytes_">Full Citation</a></description></item></channel></rss>